by S. Nass, H. Moses
Publisher: National Academies Press 2007
Number of pages: 252
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition.
Home page url
Download or read it online for free here:
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.
by Jianyuan Chai (ed.) - InTech
Angiogenesis is an extension process of the cardiovascular network. It is usually triggered by the demand of oxygen and nutrients from the fast growing tissue and uncontrollably dividing cells, as seen during wound healing and tumor progression.
by Raimundas Lunevicius - InTech
The era of therapy for GISTs is being proclaimed as bringing the message of special importance to the pathologist role in multidisciplinary team that are responsible for treating patients with locally advanced or metastatic GIST.
by Jeffrey B. Hoag (ed.) - InTech
According to the American Cancer Society, more than 1.6 million people will be diagnosed with cancer during this year. Evidence supports rapid activation of critical care services leading to improved outcomes in cancer patients.